Dr Reddy's completes acquisition of Teva's US portfolio of 8 products
Hyderabad based pharmaceutical company, Dr. Reddy's announced that it has successfully completed the acquisition of eight Abbreviated New Drug Applications (ANDAs) in the US from Teva Pharmaceuticals Industries and an affiliate of Allergan Plc. The acquired portfolio consists of products that are being divested by Teva as a precondition to its closing of acquisition of Allergan's generics business. In June, the company had entered an agreement with Teva to buy this portfolio of ANDAs for $ 350 million.
Dr. Reddy's Laboratories, is an Indian multinational pharmaceutical company based in Hyderabad, Telangana, India. The company was founded by Anji Reddy, who previously worked in the mentor institute, Indian Drugs and Pharmaceuticals Limited, of Hyderabad, India. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas.
Dr. Reddy's Laboratories, is an Indian multinational pharmaceutical company based in Hyderabad, Telangana, India. The company was founded by Anji Reddy, who previously worked in the mentor institute, Indian Drugs and Pharmaceuticals Limited, of Hyderabad, India. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas.
So let's do:
1. Name the company, which has announced that it has successfully completed the acquisition of 8 Abbreviated New Drug Applications (ANDAs) in the US from Teva Pharmaceuticals Industries?
0 Comment to "Dr Reddy's completes acquisition of Teva's US portfolio of 8 products"
Post a Comment